GPT and Cirrhosis: Over a median of 24.5 months follow-up after DAA treatment, 3 of the 52 (5.77%) HBV/HCV patients developed hepatic decompensation at month 36, 6 and 42 due to advanced cirrhosis rather than HBV reactivation, since ALT level remained consistently normal and there was no evidence of acute exacerbation.